FibroGen Stock Forecast - Accumulation Distribution
| FGEN Stock | USD 0.42 0.03 7.69% |
FibroGen Stock Forecast is based on your current time horizon. Although FibroGen's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of FibroGen's systematic risk associated with finding meaningful patterns of FibroGen fundamentals over time.
FibroGen |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 105274.0 | 50827.75 |
| Check FibroGen Volatility | Backtest FibroGen | Trend Details |
FibroGen Trading Date Momentum
| On November 07 2024 FibroGen was traded for 0.31 at the closing time. The top price for the day was 0.33 and the lowest listed price was 0.30 . The trading volume for the day was 996.5 K. The trading history from November 7, 2024 did not affect price variability. The overall trading delta against the current closing price is 3.23% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare FibroGen to competition |
Other Forecasting Options for FibroGen
For every potential investor in FibroGen, whether a beginner or expert, FibroGen's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. FibroGen Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in FibroGen. Basic forecasting techniques help filter out the noise by identifying FibroGen's price trends.FibroGen Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FibroGen stock to make a market-neutral strategy. Peer analysis of FibroGen could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
FibroGen Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of FibroGen's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of FibroGen's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
FibroGen Market Strength Events
Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns.
FibroGen Risk Indicators
The analysis of FibroGen's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in FibroGen's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fibrogen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.76 | |||
| Semi Deviation | 5.45 | |||
| Standard Deviation | 6.45 | |||
| Variance | 41.66 | |||
| Downside Variance | 48.53 | |||
| Semi Variance | 29.66 | |||
| Expected Short fall | (6.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with FibroGen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if FibroGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will appreciate offsetting losses from the drop in the long position's value.Moving against FibroGen Stock
| 0.62 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.55 | GANX | Gain Therapeutics | PairCorr |
| 0.51 | BHC | Bausch Health Companies | PairCorr |
| 0.48 | GILD | Gilead Sciences | PairCorr |
| 0.45 | EBS | Emergent Biosolutions | PairCorr |
The ability to find closely correlated positions to FibroGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FibroGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FibroGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FibroGen to buy it.
The correlation of FibroGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FibroGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of FibroGen to cross-verify your projections. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (1.23) | Revenue Per Share 1.758 | Quarterly Revenue Growth 0.143 | Return On Assets (0.27) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.